Cantor Fitzgerald: Here's why investment in China is attractive
Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
Cantor Fitzgerald Initiates Coverage on Varonis Systems, Inc. (VRNS) with Overweight Rating: AI and Cybersecurity Drive Growth Outlook
We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...
Fintel on MSN2d
Cantor Fitzgerald Initiates Coverage of Voyager Therapeutics (VYGR) with Overweight Recommendation
Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a ...
Cantor Fitzgerald Predicts Weaker Earnings for Maplebear
Stock analysts at Cantor Fitzgerald dropped their FY2024 earnings per share estimates for Maplebear in a research note issued on Tuesday, January 7th. Cantor Fitzgerald analyst D. Mathivanan now ...
Cantor Fitzgerald Raises Amazon.com, Inc. (AMZN)’s Price Target to $270, Highlighting Strong AI Growth and Future Potential
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Cantor Fitzgerald Initiates Coverage on Check Point Software Technologies (NASDAQ:CHKP)
Cantor Fitzgerald initiated coverage on shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) in a research ...
Zevra Therapeutics assumed with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, ...
Varonis initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of Varonis (VRNS) with an Overweight rating and $60 price target The firm believes data security is ...
Cantor Fitzgerald, L.P.: Cantor Equity Partners I, Inc. Announces Closing of $200 Million Initial Public Offering
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering ...
Cantor Fitzgerald, L.P.: Cantor Equity Partners I, Inc. Announces Pricing of $200 Million Initial Public Offering
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering ...
Nasdaq5d
Cantor Fitzgerald Europe Increases Stake in Cambridge Nutritional Sciences
Cambridge Nutritional Sciences PLC has announced that Cantor Fitzgerald Europe has crossed the 5% threshold in its voting rights, now holding 5.207% of the total voting rights. This acquisition of ...
Nasdaq5d
Zevra Therapeutics assumed with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...